Episode Details
Back to Episodes
Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up
Published 6 months, 3 weeks ago
Description
In today’s Pharmaceutical Executive Daily, we cover market reaction to Novo Nordisk’s recent board shake-up, MJH Life Sciences’ acquisition of BPD Healthcare to strengthen its health system reach, and why clinical trial site satisfaction is becoming a key competitive differentiator for sponsors and CROs.